The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging
Open accessAbstract
A retrospective analysis was performed to evaluate the clinical characteristics and prognostic factors in the patients with clear cell carcinoma (CCC) of the ovary. After central pathological review and scanning of the medical records of nine Japanese institutions between 1992 and 2003, a total of 254 patients with CCC of the ovary were enrolled in the present study. Mean age was 52.4 years (range 23-73 years). Tumours were 13% (33/254) stage Ia, 36% (92/254) stage Ic, 13% (33/254) stage II, 30% (80/254) stage III, and 6% (16/254) stage IV. Five-year progression-free survival and overall survival was 84 and 88% in stage I, 57 and 70% in stage II, 25 and 33% in stage III and 0 and 0% in stage IV, respectively. Retroperitoneal lymph node metastasis was observed in 9% in pT1a tumours, 7% in pT1c tumours, 13% in pT2 tumours, and 58% in pT3 tumours, respectively. There was no survival benefit according to chemotherapeutic differences in the patients who received complete surgical staging procedures and conventional chemotherapy. Peritoneal cytological status was an independent prognostic factor in stage Ic patients (P=0.03) and only residual tumour diameter was an independent prognostic factor in stage III, IV patients (P=0.02). Our results suggest that cytoreductive surgery resulting in no residual tumour only could improve the prognosis of advanced CCC patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Edwards, B. K., Brown, M. L., Wingo, P. A., Howe, H. L., Ward, E., Ries, L. A. G., Schrag, D., Jamison, P. M., Jemal, A., Wu, X. C., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji289 · Cited by 952
Sugiyama, T., Kamura, T., Kigawa, J., Terakawa, N., Kikuchi, Y., Kita, T., Suzuki, M., Sato, I., & Taguchi, K. (2000) · Cancer · doi:10.1002/1097-0142(20000601)88:11<2584::aid-cncr22>3.0.co;2-5 · Cited by 795
Self-citationTrimbos, J. B., Vergote, I., Bolis, G., Vermorken, J. B., Mangioni, C., Madronal, C., Franchi, M., Tateo, S., Zanetta, G., Scarfone, G., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.2.113 · Cited by 674
Expression Profiling in Ovarian Clear Cell Carcinoma
Tsuchiya, A., Sakamoto, M., Yasuda, J., Chuma, M., Ohta, T., Ohki, M., Yasugi, T., Taketani, Y., & Hirohashi, S. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63605-x · Cited by 308
Morice, P., Joulie, F., Camatte, S., Atallah, D., Rouzier, R., Pautier, P., Pomel, C., Lhommé, C., Duvillard, P., & Castaigne, D. (2003) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(03)00234-5 · Cited by 275
Ovarian clear cell adenocarcinoma
Kennedy, A. W., Biscotti, C. V., Hart, W. R., & Webster, K. D. (1989) · Gynecologic Oncology · doi:10.1016/0090-8258(89)90637-9 · Cited by 178
Clear cell adenocarcinoma of the ovary: A clinical analysis and comparison with serous carcinoma
Jenison, E. L., Montag, A. G., Griffiths, C. T., Welch, W. R., Lavin, P. T., Greer, J., & Knapp, R. C. (1989) · Gynecologic Oncology · doi:10.1016/0090-8258(89)90852-4 · Cited by 164
[International Histologic Classification of Tumors].
Lh, S. (1982) · PubMed · Cited by 158
Itamochi, H., Kigawa, J., Sugiyama, T., Kikuchi, Y., Suzuki, M., & Terakawa, N. (2002) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(02)02040-9 · Cited by 155
Self-citationClear cell carcinoma of the ovary: A study of 59 cases
Crozier, M., Copeland, L. J., Silva, E. G., Gershenson, D. M., & Stringer, C. A. (1989) · Gynecologic Oncology · doi:10.1016/0090-8258(89)90043-7 · Cited by 151
Bray, F., Loos, A. H., Tognazzo, S., & Vecchia, C. L. (2004) · International Journal of Cancer · doi:10.1002/ijc.20649 · Cited by 149
Clinical Characteristics of Clear Cell Carcinoma of the Ovary
Behbakht, K., Randall, T. C., Benjamin, I., Morgan, M. A., King, S. A., & Rubin, S. C. (1998) · Gynecologic Oncology · doi:10.1006/gyno.1998.5071 · Cited by 149
Cass, I. A., Li, A. J., Runowicz, C. D., Fields, A. L., Goldberg, G. L., Leuchter, R. S., Lagasse, L. D., & Karlan, B. Y. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2000.6027 · Cited by 127
Ho, C., Huang, R. Y., Chen, T.-C., Huang, S., Liu, F.-S., Chien, C.-C. C., Yu, M.-H., Mao, T., Wang, T., & Hsieh, C. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.04.004 · Cited by 102
Histologic typing of ovarian tumors.
Scully, R. E., & Sobin, L. H. (1987) · PubMed · Cited by 102
Long-Term Prognosis of Stage I Ovarian Carcinoma
Mizuno, M., Kikkawa, F., Shibata, K., et al. (2003) · Oncology · doi:10.1159/000071202 · Cited by 66
Ho, C., Chien, T.-Y., Shih, B.-Y., et al. (2003) · Gynecologic Oncology · doi:10.1016/s0090-8258(02)00156-7 · Cited by 64
Clear cell ovarian adenocarcinoma
Yoonessi, M., Facog, D. W., Satchidand, S. K., & Crickard, K. (1984) · Journal of Surgical Oncology · doi:10.1002/jso.2930270420 · Cited by 39
Exploratory study of effective chemotherapy to clear cell carcinoma of the ovary.
Kita, T., Kikuchi, Y., Kudoh, K., Takano, M., Goto, T., Hirata, J., Tode, T., & Nagata, I. (2000) · Oncology Reports · doi:10.3892/or.7.2.327 · Cited by 34
Self-citation
Cited by
Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
Köbel, M., Kalloger, S. E., Boyd, N., McKinney, S., Mehl, E., Palmer, C., Leung, S., Bowen, N. J., Ionescu, D. N., Rajput, A., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050232 · Cited by 814
“The dismal response rate of clear cell carcinomas (15%) contrasts sharply with that of high-grade serous (80%), resulting in a lower 5-y survival for clear cell compared with high-grade serous carcinoma in patients with advanced stage tumors (20% versus 30%) [7,8].”
BackgroundPrat, J. (2012) · Virchows Archiv · doi:10.1007/s00428-012-1203-5 · Cited by 602
Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell Carcinoma
Kuo, K.-T., Mao, T.-L., Jones, S., Veras, E., Ayhan, A., Wang, T.-L., Glas, R., Slamon, D., Velculescu, V. E., Kuman, R. J., et al. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.081000 · Cited by 485
New insights into ovarian cancer pathology
Prat, J. (2012) · Annals of Oncology · doi:10.1093/annonc/mds300 · Cited by 317
Anglesio, M. S., Carey, M. S., Köbel, M., MacKay, H., & Huntsman, D. G. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.01.005 · Cited by 272
Metadata
- Authors
- Takano, M., Kikuchi, Y., Yaegashi, N., Kuzuya, K., Ueki, M., Tsuda, H., Suzuki, M., Kigawa, J., Takeuchi, S., Tsuda, H., Moriya, T., & Sugiyama, T.
- Venue
- British Journal of Cancer
- Published
- 2006-04-25
- Volume
- 94
- Issue
- 10
- Pages
- 1369-1374
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2025423482
- Cited by
- 266
- References
- 19
- FWCI
- 8.74
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.